Assanto GM - Search Results

1

High Basal Maximal Standardized Uptake Value (SUV_max) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse.

Assanto GM, Ciotti G, Brescini M, De Luca ML, Annechini G, D'Elia GM, Agrippino R, Del Giudice I, Martelli M, Chiaravalloti A, Pulsoni A. Assanto GM, et al. Cancers (Basel). 2021 Jun 9;13(12):2876. doi: 10.3390/cancers13122876. Cancers (Basel). 2021. PMID: 34207518 Free PMC article.

2

Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.

Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, Carmini D, La Rocca U, De Propris MS, Trisolini SM, Brescini M, Galassi G, Barberi W, Iori AP. Bruzzese A, et al. Among authors: assanto gm. Bone Marrow Transplant. 2021 Jun;56(6):1455-1457. doi: 10.1038/s41409-020-01174-w. Epub 2021 Jan 29. Bone Marrow Transplant. 2021. PMID: 33514926 No abstract available.

3

Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.

Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, Carmini D, La Rocca U, De Propris MS, Trisolini SM, Brescini M, Galassi G, Barberi W, Iori AP. Bruzzese A, et al. Among authors: assanto gm. Bone Marrow Transplant. 2021 Jun;56(6):1482. doi: 10.1038/s41409-021-01242-9. Bone Marrow Transplant. 2021. PMID: 33637883 No abstract available.

4

The current role of interferon in hairy cell leukaemia: clinical and molecular aspects.

Assanto GM, Riemma C, Malaspina F, Perrone S, De Luca ML, Pucciarini A, Annechini G, D'Elia GM, Martelli M, Foà R, Tiacci E, Pulsoni A. Assanto GM, et al. Br J Haematol. 2021 Jul;194(1):78-82. doi: 10.1111/bjh.17440. Epub 2021 May 1. Br J Haematol. 2021. PMID: 33932027 Free PMC article.

5

Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic.

Micozzi A, Assanto GM, Cesini L, Minotti C, Cartoni C, Capria S, Ciotti G, Alunni Fegatelli D, Donzelli L, Martelli M, Gentile G. Micozzi A, et al. Among authors: assanto gm. JAC Antimicrob Resist. 2021 Nov 17;3(4):dlab167. doi: 10.1093/jacamr/dlab167. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34806006 Free PMC article.

6

Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients.

Serrao A, Assanto GM, Mormile R, Brescini M, Santoro C, Chistolini A. Serrao A, et al. Among authors: assanto gm. Intern Emerg Med. 2022 Jun;17(4):1081-1085. doi: 10.1007/s11739-021-02917-3. Epub 2022 Jan 11. Intern Emerg Med. 2022. PMID: 35018544

7

Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.

Di Rocco A, Petrucci L, Assanto GM, Martelli M, Pulsoni A. Di Rocco A, et al. Among authors: assanto gm. Cancers (Basel). 2022 Mar 29;14(7):1742. doi: 10.3390/cancers14071742. Cancers (Basel). 2022. PMID: 35406516 Free PMC article. Review.

8

RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort.

Scalzulli E, Ielo C, Luise C, Musiu P, Bisegna ML, Carmosino I, Assanto GM, Martelli M, Breccia M. Scalzulli E, et al. Among authors: assanto gm. Blood Adv. 2022 Aug 9;6(15):4424-4426. doi: 10.1182/bloodadvances.2022008158. Blood Adv. 2022. PMID: 35737865 Free PMC article. No abstract available.

9

Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors.

Breccia M, Assanto GM, Laganà A, Scalzulli E, Martelli M. Breccia M, et al. Among authors: assanto gm. Curr Opin Oncol. 2022 Nov 1;34(6):729-737. doi: 10.1097/CCO.0000000000000898. Epub 2022 Aug 26. Curr Opin Oncol. 2022. PMID: 36017560 Review.

10

From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care.

Assanto GM, Scalzulli E, Carmosino I, Martelli M, Breccia M. Assanto GM, et al. Expert Rev Hematol. 2022 Nov;15(11):963-971. doi: 10.1080/17474086.2022.2142112. Epub 2022 Nov 1. Expert Rev Hematol. 2022. PMID: 36305791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters